Wolfgang Kothny
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Association between vildagliptin and risk of angioedema, foot ulcers, skin lesions, hepatic toxicity, and serious infections in patients with type 2 diabetes mellitus: A European multidatabase, noninterventional, postauthorization safety study.
Journal: Endocrinology, diabetes & metabolism
Published: May 08, 2019
Pancreatic safety of vildagliptin in patients with type 2 diabetes mellitus: A European, noninterventional, postauthorization safety study.
Journal: Endocrinology, diabetes & metabolism
Published: October 23, 2018
Estimands: A More Strategic Approach to Study Design and Analysis.
Journal: Clinical pharmacology and therapeutics
Published: July 25, 2017
Effects of Vildagliptin on Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure: A Randomized Placebo-Controlled Trial.
Journal: JACC. Heart failure
Published: May 14, 2017
Cardiovascular safety of vildagliptin in patients with type 2 diabetes: A European multi-database, non-interventional post-authorization safety study.
Journal: Diabetes, obesity & metabolism
Published: December 21, 2016
Effect of race and ethnicity on vildagliptin efficacy: A pooled analysis of phase II and III studies.
Journal: Diabetes, obesity & metabolism
Published: July 21, 2016
Cardiovascular and heart failure safety profile of vildagliptin: a meta-analysis of 17 000 patients.
Cardiovascular and heart failure safety profile of vildagliptin: a meta-analysis of 17 000 patients.
Journal: Diabetes, obesity & metabolism
Published: May 15, 2015
Comparison of vildagliptin and sitagliptin in patients with type 2 diabetes and severe renal impairment: a randomised clinical trial.
Journal: Diabetologia
Published: February 17, 2015
Vildagliptin as add-on therapy to insulin improves glycemic control without increasing risk of hypoglycemia in Asian, predominantly Chinese, patients with type 2 diabetes mellitus.
Journal: Journal of diabetes
Published: February 12, 2015
Efficacy and safety of a single-pill combination of vildagliptin and metformin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: December 24, 2014
Vildagliptin in patients with type 2 diabetes mellitus and renal impairment.
Journal: Diabetes research and clinical practice
Published: May 07, 2014
Last Updated: 09/26/2026